Neoplasms, Colorectal Completed Phase 3 Trials for Regorafenib (DB08896)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01853319Regorafenib in Subjects With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard TherapyTreatment
NCT01584830Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard TherapyTreatment